Jeffrey Dierks, CHIEF COMMERCIAL OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 72,009 shares at $35.05 ($2.5M) on 2024-10-03, disclosed to the SEC on 2024-10-07.
Open-market sale of $2.5M HRMY by CHIEF COMMERCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.05 | 35,652 | $1.2M | 49.5% |
| 2 | $35.05 | 35,652 | $1.2M | 49.5% |
| 3 | $35.62 | 705 | $25K | 1.0% |
| Total | $35.06 avg | 72,009 | $2.5M | 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |